Global COVID-19 Molecular Diagnostics Market Growth (Status and Outlook) 2023-2029

March 2023 | 103 pages | ID: G0FE37FB9CC6EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

COVID-19 has seen the molecular in vitro diagnostics (IVD) industry bring out its best efforts in terms of fast test RT-PCR tests for their systems, point of care solutions, syndromic tests, high throughput systems and surge production on badly needed kits.

According to this study, the global COVID-19 Molecular Diagnostics market size will reach US$ million by 2029.

This report presents a comprehensive overview, market shares, and growth opportunities of COVID-19 Molecular Diagnostics market by product type, application, key players and key regions and countries.

Segmentation by product type:
  • High-throughput Sequencing
  • Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
  • Immunological Detection
Segmentation by Application:
  • Hospitals
  • Scientific Research
  • Biodiagnostics
This report also splits the market by region:
  • United States
  • China
  • Europe
  • Other regions:
    • Japan
    • South Korea
    • Southeast Asia
    • Rest of world
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
  • Cellex
  • Abbott
  • Roche
  • BioMedomics
  • BD
  • Henry Schein
  • Safecare Bio-Tech
  • Thermo Fisher
  • Bio-rad
  • Agilent
  • Ortho Clinical Diagnostics
  • Zhejiang Orient Gene Biotech
  • Innovita Biological Technology
  • Guangzhou Wondfo Biotech
  • Guangdong Hecin-Scientific
  • Dynamiker Biotechnology (Tianjin)
  • ADVAITE
  • Mayo Clinic Laboratories
  • Chembio Diagnostics
  • Mount Sinai Laboratory
  • QIAGEN
  • Bioer
  • Biosynex
  • Esco
  • Analytik Jena
  • Techne
  • Da An Gene
  • BGI
  • Shanghai ZJ Bio-Tech
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global COVID-19 Molecular Diagnostics Market Size 2024-2029
  2.1.2 COVID-19 Molecular Diagnostics Market Size CAGR by Region
2.2 COVID-19 Molecular Diagnostics Segment by Type
  2.2.1 High-throughput Sequencing
  2.2.2 Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
  2.2.3 Immunological Detection
2.3 COVID-19 Molecular Diagnostics Market Size by Type
  2.3.1 Global COVID-19 Molecular Diagnostics Market Size Market Share by Type (2024-2029)
  2.3.2 Global COVID-19 Molecular Diagnostics Market Size Growth Rate by Type (2024-2029)
2.4 COVID-19 Molecular Diagnostics Segment by Application
  2.4.1 Hospitals
  2.4.2 Scientific Research
  2.4.3 Biodiagnostics
2.5 COVID-19 Molecular Diagnostics Market Size by Application
  2.5.1 Global COVID-19 Molecular Diagnostics Market Size Market Share by Application (2024-2029)
  2.5.2 Global COVID-19 Molecular Diagnostics Market Size Growth Rate by Application (2024-2029)

3 COVID-19 MOLECULAR DIAGNOSTICS KEY PLAYERS

3.1 Date of Key Players Enter into COVID-19 Molecular Diagnostics
3.2 Key Players COVID-19 Molecular Diagnostics Product Offered
3.3 Key Players COVID-19 Molecular Diagnostics Funding/Investment Analysis
3.4 Funding/Investment
  3.4.1 Funding/Investment by Regions
  3.4.2 Funding/Investment by End-Industry
3.5 Key Players COVID-19 Molecular Diagnostics Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions

4 COVID-19 MOLECULAR DIAGNOSTICS BY REGIONS

4.1 COVID-19 Molecular Diagnostics Market Size by Regions (2024-2029)
4.2 United States COVID-19 Molecular Diagnostics Market Size Growth (2024-2029)
4.3 China COVID-19 Molecular Diagnostics Market Size Growth (2024-2029)
4.4 Europe COVID-19 Molecular Diagnostics Market Size Growth (2024-2029)
4.5 Rest of World COVID-19 Molecular Diagnostics Market Size Growth (2024-2029)

5 UNITED STATES

5.1 United States COVID-19 Molecular Diagnostics Market Size by Type (2024-2029)
5.2 United States COVID-19 Molecular Diagnostics Market Size by Application (2024-2029)

6 EUROPE

6.1 Europe COVID-19 Molecular Diagnostics Market Size by Type (2024-2029)
6.2 Europe COVID-19 Molecular Diagnostics Market Size by Application (2024-2029)

7 CHINA

7.1 China COVID-19 Molecular Diagnostics Market Size by Type (2024-2029)
7.2 China COVID-19 Molecular Diagnostics Market Size by Application (2024-2029)

8 REST OF WORLD

8.1 Rest of World COVID-19 Molecular Diagnostics Market Size by Type (2024-2029)
8.2 Rest of World COVID-19 Molecular Diagnostics Market Size by Application (2024-2029)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 KEY INVESTORS IN COVID-19 MOLECULAR DIAGNOSTICS

10.1 Company A
  10.1.1 Company A Company Details
  10.1.2 Company Description
  10.1.3 Companies Invested by Company A
  10.1.4 Company A Key Development and Market Layout
10.2 Company B
  10.2.1 Company B Company Details
  10.2.2 Company Description
  10.2.3 Companies Invested by Company B
  10.2.4 Company B Key Development and Market Layout
10.3 Company C
  10.3.1 Company C Company Details
  10.3.2 Company Description
  10.3.3 Companies Invested by Company C
  10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……

11 KEY PLAYERS ANALYSIS

11.1 Cellex
  11.1.1 Cellex Company Details
  11.1.2 Cellex COVID-19 Molecular Diagnostics Product Offered
  11.1.3 Cellex COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
  11.1.4 Cellex Main Business Overview
  11.1.5 Cellex News
11.2 Abbott
  11.2.1 Abbott Company Details
  11.2.2 Abbott COVID-19 Molecular Diagnostics Product Offered
  11.2.3 Abbott COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
  11.2.4 Abbott Main Business Overview
  11.2.5 Abbott News
11.3 Roche
  11.3.1 Roche Company Details
  11.3.2 Roche COVID-19 Molecular Diagnostics Product Offered
  11.3.3 Roche COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
  11.3.4 Roche Main Business Overview
  11.3.5 Roche News
11.4 BioMedomics
  11.4.1 BioMedomics Company Details
  11.4.2 BioMedomics COVID-19 Molecular Diagnostics Product Offered
  11.4.3 BioMedomics COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
  11.4.4 BioMedomics Main Business Overview
  11.4.5 BioMedomics News
11.5 BD
  11.5.1 BD Company Details
  11.5.2 BD COVID-19 Molecular Diagnostics Product Offered
  11.5.3 BD COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
  11.5.4 BD Main Business Overview
  11.5.5 BD News
11.6 Henry Schein
  11.6.1 Henry Schein Company Details
  11.6.2 Henry Schein COVID-19 Molecular Diagnostics Product Offered
  11.6.3 Henry Schein COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
  11.6.4 Henry Schein Main Business Overview
  11.6.5 Henry Schein News
11.7 Safecare Bio-Tech
  11.7.1 Safecare Bio-Tech Company Details
  11.7.2 Safecare Bio-Tech COVID-19 Molecular Diagnostics Product Offered
  11.7.3 Safecare Bio-Tech COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
  11.7.4 Safecare Bio-Tech Main Business Overview
  11.7.5 Safecare Bio-Tech News
11.8 Thermo Fisher
  11.8.1 Thermo Fisher Company Details
  11.8.2 Thermo Fisher COVID-19 Molecular Diagnostics Product Offered
  11.8.3 Thermo Fisher COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
  11.8.4 Thermo Fisher Main Business Overview
  11.8.5 Thermo Fisher News
11.9 Bio-rad
  11.9.1 Bio-rad Company Details
  11.9.2 Bio-rad COVID-19 Molecular Diagnostics Product Offered
  11.9.3 Bio-rad COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
  11.9.4 Bio-rad Main Business Overview
  11.9.5 Bio-rad News
11.10 Agilent
  11.10.1 Agilent Company Details
  11.10.2 Agilent COVID-19 Molecular Diagnostics Product Offered
  11.10.3 Agilent COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
  11.10.4 Agilent Main Business Overview
  11.10.5 Agilent News
11.11 Ortho Clinical Diagnostics
11.12 Zhejiang Orient Gene Biotech
11.13 Innovita Biological Technology
11.14 Guangzhou Wondfo Biotech
11.15 Guangdong Hecin-Scientific
11.16 Dynamiker Biotechnology (Tianjin)
11.17 ADVAITE
11.18 Mayo Clinic Laboratories
11.19 Chembio Diagnostics
11.20 Mount Sinai Laboratory
11.21 QIAGEN
11.22 Bioer
11.23 Biosynex
11.24 Esco
11.25 Analytik Jena
11.26 Techne
11.27 Da An Gene
11.28 BGI
11.29 Shanghai ZJ Bio-Tech

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. COVID-19 Molecular Diagnostics Market Size CAGR by Region (2024-2029) ($ Millions)
Table 2. Major Players of High-throughput Sequencing
Table 3. Major Players of Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR
Table 4. Major Players of Immunological Detection
Table 5. Global COVID-19 Molecular Diagnostics Market Size by Type (2024-2029) ($ Millions)
Table 6. Global COVID-19 Molecular Diagnostics Market Size Market Share by Type (2024-2029)
Table 7. Global COVID-19 Molecular Diagnostics Market Size by Application (2024-2029) ($ Millions)
Table 8. Global COVID-19 Molecular Diagnostics Market Size Market Share by Application (2024-2029)
Table 9. Date of Global Key Players Enter into COVID-19 Molecular Diagnostics Market
Table 10. Global Key Players COVID-19 Molecular Diagnostics Product Offered
Table 11. Key Players COVID-19 Molecular Diagnostics Funding/Investment ($ Millions)
Table 12. Funding/Investment by Regions
Table 13. Funding/Investment by End Industry
Table 14. Key Players COVID-19 Molecular Diagnostics Valuation & Market Capitalization ($ Millions)
Table 15. Key Players Mergers & Acquisitions, Expansion Plans
Table 16. COVID-19 Molecular Diagnostics New Product/Technology Launches
Table 17. COVID-19 Molecular Diagnostics Industry Partnerships, Agreements, and Collaborations
Table 18. COVID-19 Molecular Diagnostics Industry Mergers and Acquisitions
Table 19. Global COVID-19 Molecular Diagnostics Market Size by Regions 2024-2029 ($ Millions)
Table 20. Global COVID-19 Molecular Diagnostics Market Size Market Share by Regions 2024-2029
Table 21. United States COVID-19 Molecular Diagnostics Market Size by Type (2024-2029) ($ Millions)
Table 22. United States COVID-19 Molecular Diagnostics Market Size Market Share by Type (2024-2029)
Table 23. United States COVID-19 Molecular Diagnostics Market Size by Application (2024-2029) ($ Millions)
Table 24. United States COVID-19 Molecular Diagnostics Market Size Market Share by Application (2024-2029)
Table 25. Europe COVID-19 Molecular Diagnostics Market Size by Type (2024-2029) ($ Millions)
Table 26. Europe COVID-19 Molecular Diagnostics Market Size Market Share by Type (2024-2029)
Table 27. Europe COVID-19 Molecular Diagnostics Market Size by Application (2024-2029) ($ Millions)
Table 28. Europe COVID-19 Molecular Diagnostics Market Size Market Share by Application (2024-2029)
Table 29. China COVID-19 Molecular Diagnostics Market Size by Type (2024-2029) ($ Millions)
Table 30. China COVID-19 Molecular Diagnostics Market Size Market Share by Type (2024-2029)
Table 31. China COVID-19 Molecular Diagnostics Market Size by Application (2024-2029) ($ Millions)
Table 32. China COVID-19 Molecular Diagnostics Market Size Market Share by Application (2024-2029)
Table 33. Rest of World COVID-19 Molecular Diagnostics Market Size by Type (2024-2029) ($ Millions)
Table 34. Rest of World COVID-19 Molecular Diagnostics Market Size Market Share by Type (2024-2029)
Table 35. Rest of World COVID-19 Molecular Diagnostics Market Size by Application (2024-2029) ($ Millions)
Table 36. Rest of World COVID-19 Molecular Diagnostics Market Size Market Share by Application (2024-2029)
Table 37. Key Market Drivers & Growth Opportunities of COVID-19 Molecular Diagnostics
Table 38. Key Market Challenges & Risks of COVID-19 Molecular Diagnostics
Table 39. Key Industry Trends of COVID-19 Molecular Diagnostics
Table 40. Company A Company Details
Table 41. Companies Invested by Company A
Table 42. Company A Key Development and Market Layout
Table 43. Company B Company Details
Table 44. Companies Invested by Company B
Table 45. Company B Key Development and Market Layout
Table 46. Company C Company Details
Table 47. Companies Invested by Company C
Table 48. Company C Key Development and Market Layout
Table 49. Company C Company Details
Table 50. Companies Invested by Company C
Table 51. Company C Key Development and Market Layout
Table 52. Cellex Basic Information, Head Office, Major Market Areas and Its Competitors
Table 53. Cellex COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
Table 54. Abbott Basic Information, Head Office, Major Market Areas and Its Competitors
Table 55. Abbott COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
Table 56. Roche Basic Information, Head Office, Major Market Areas and Its Competitors
Table 57. Roche COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
Table 58. BioMedomics Basic Information, Head Office, Major Market Areas and Its Competitors
Table 59. BioMedomics COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
Table 60. BD Basic Information, Head Office, Major Market Areas and Its Competitors
Table 61. BD COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
Table 62. Henry Schein Basic Information, Head Office, Major Market Areas and Its Competitors
Table 63. Henry Schein COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
Table 64. Safecare Bio-Tech Basic Information, Head Office, Major Market Areas and Its Competitors
Table 65. Safecare Bio-Tech COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
Table 66. Thermo Fisher Basic Information, Head Office, Major Market Areas and Its Competitors
Table 67. Thermo Fisher COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
Table 68. Bio-rad Basic Information, Head Office, Major Market Areas and Its Competitors
Table 69. Bio-rad COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
Table 70. Agilent Basic Information, Head Office, Major Market Areas and Its Competitors
Table 71. Agilent COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
Table 72. Ortho Clinical Diagnostics Basic Information, Head Office, Major Market Areas and Its Competitors
Table 73. Ortho Clinical Diagnostics COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
Table 74. Zhejiang Orient Gene Biotech Basic Information, Head Office, Major Market Areas and Its Competitors
Table 75. Zhejiang Orient Gene Biotech COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
Table 76. Innovita Biological Technology Basic Information, Head Office, Major Market Areas and Its Competitors
Table 77. Innovita Biological Technology COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
Table 78. Guangzhou Wondfo Biotech Basic Information, Head Office, Major Market Areas and Its Competitors
Table 79. Guangzhou Wondfo Biotech COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
Table 80. Guangdong Hecin-Scientific Basic Information, Head Office, Major Market Areas and Its Competitors
Table 81. Guangdong Hecin-Scientific COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
Table 82. Dynamiker Biotechnology (Tianjin) Basic Information, Head Office, Major Market Areas and Its Competitors
Table 83. Dynamiker Biotechnology (Tianjin) COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
Table 84. ADVAITE Basic Information, Head Office, Major Market Areas and Its Competitors
Table 85. ADVAITE COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
Table 86. Mayo Clinic Laboratories Basic Information, Head Office, Major Market Areas and Its Competitors
Table 87. Mayo Clinic Laboratories COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
Table 88. Chembio Diagnostics Basic Information, Head Office, Major Market Areas and Its Competitors
Table 89. Chembio Diagnostics COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
Table 90. Mount Sinai Laboratory Basic Information, Head Office, Major Market Areas and Its Competitors
Table 91. Mount Sinai Laboratory COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
Table 92. QIAGEN Basic Information, Head Office, Major Market Areas and Its Competitors
Table 93. QIAGEN COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
Table 94. Bioer Basic Information, Head Office, Major Market Areas and Its Competitors
Table 95. Bioer COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
Table 96. Biosynex Basic Information, Head Office, Major Market Areas and Its Competitors
Table 97. Biosynex COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
Table 98. Esco Basic Information, Head Office, Major Market Areas and Its Competitors
Table 99. Esco COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
Table 100. Analytik Jena Basic Information, Head Office, Major Market Areas and Its Competitors
Table 101. Analytik Jena COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
Table 102. Techne Basic Information, Head Office, Major Market Areas and Its Competitors
Table 103. Techne COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
Table 104. Da An Gene Basic Information, Head Office, Major Market Areas and Its Competitors
Table 105. Da An Gene COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
Table 106. BGI Basic Information, Head Office, Major Market Areas and Its Competitors
Table 107. BGI COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)
Table 108. Shanghai ZJ Bio-Tech Basic Information, Head Office, Major Market Areas and Its Competitors
Table 109. Shanghai ZJ Bio-Tech COVID-19 Molecular Diagnostics Market Size (2023 VS 2029)

LIST OF FIGURES

Figure 1. Picture of COVID-19 Molecular Diagnostics
Figure 2. COVID-19 Molecular Diagnostics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global COVID-19 Molecular Diagnostics Market Size Growth Rate 2024-2029 ($ Millions)
Figure 7. COVID-19 Molecular Diagnostics Market Size by Region (2023 & 2029) ($ millions)
Figure 8. Global COVID-19 Molecular Diagnostics Market Size Market Share by Type (2024-2029)
Figure 9. Global High-throughput Sequencing Market Size Growth Rate
Figure 10. Global Nucleic Acid Detection Based on Real-time Fluorescent Quantitative PCR Market Size Growth Rate
Figure 11. Global Immunological Detection Market Size Growth Rate
Figure 12. COVID-19 Molecular Diagnostics in Hospitals
Figure 13. Global COVID-19 Molecular Diagnostics Market: Hospitals (2024-2029) ($ Millions)
Figure 14. COVID-19 Molecular Diagnostics in Scientific Research
Figure 15. Global COVID-19 Molecular Diagnostics Market: Scientific Research (2024-2029) ($ Millions)
Figure 16. COVID-19 Molecular Diagnostics in Biodiagnostics
Figure 17. Global COVID-19 Molecular Diagnostics Market: Biodiagnostics (2024-2029) ($ Millions)
Figure 18. Global COVID-19 Molecular Diagnostics Market Size Market Share by Application (2024-2029)
Figure 19. Global COVID-19 Molecular Diagnostics Market Size in Hospitals Growth Rate
Figure 20. Global COVID-19 Molecular Diagnostics Market Size in Scientific Research Growth Rate
Figure 21. Global COVID-19 Molecular Diagnostics Market Size in Biodiagnostics Growth Rate
Figure 22. Funding/Investment
Figure 23. Global COVID-19 Molecular Diagnostics Market Size Market Share by Regions 2024-2029
Figure 24. United States COVID-19 Molecular Diagnostics Market Size 2024-2029 ($ Millions)
Figure 25. China COVID-19 Molecular Diagnostics Market Size 2024-2029 ($ Millions)
Figure 26. Europe COVID-19 Molecular Diagnostics Market Size 2024-2029 ($ Millions)
Figure 27. Rest of World COVID-19 Molecular Diagnostics Market Size 2024-2029 ($ Millions)
Figure 28. United States COVID-19 Molecular Diagnostics Consumption Market Share by Type in 2029
Figure 29. United States COVID-19 Molecular Diagnostics Market Size Market Share by Application in 2029
Figure 30. China COVID-19 Molecular Diagnostics Consumption Market Share by Type in 2029
Figure 31. China COVID-19 Molecular Diagnostics Market Size Market Share by Application in 2029
Figure 32. Europe COVID-19 Molecular Diagnostics Consumption Market Share by Type in 2029
Figure 33. Europe COVID-19 Molecular Diagnostics Market Size Market Share by Application in 2029
Figure 34. Rest of World COVID-19 Molecular Diagnostics Consumption Market Share by Type in 2029
Figure 35. Rest of World COVID-19 Molecular Diagnostics Market Size Market Share by Application in 2029


More Publications